4//SEC Filing
Beyer Russell P 4
Accession 0001437749-23-006908
CIK 0001833214other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:27 PM ET
Size
5.3 KB
Accession
0001437749-23-006908
Insider Transaction Report
Form 4
Beyer Russell P
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-14+275,000→ 275,000 totalExercise: $0.54Exp: 2033-03-14→ Common Stock (275,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
- [F2]The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001889754
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:27 PM ET
- Size
- 5.3 KB